MOVANTIK 25 MG TABLET
FDA nonproprietary name: naloxegol oxalate
For 30 tablets
Pharmacies pay
$438.40 filed
30 × $14.61317 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$405.09 filed
30 × $13.50292 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.92× estimated
Medicare paid 8% less than pharmacies pay.
Part D averages every strength and form sold under “Movantik” / “Naloxegol Oxalate” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$509.16 estimated
$438.40 + $65.76 (15%) + $5.00 fee per fill = $509.16
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
MOVANTIK 25 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as naloxegol oxalate, under the trade name “MOVANTIK”.
FDA gives its dosage form as tablet, film coated and its route as oral.
The labeler, the company named on the label, is Averitas Pharma, Inc.
FDA’s Established Pharmacologic Class for it is Opioid Antagonist.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $438.40 for 30 tablets (30 × $14.61317 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
All 2 NDCs
- 82625-8802-01 · Averitas Pharma, Inc. · $14.61317 per EA · eff. 2026-09-23 filed
- 82625-8802-03 · Averitas Pharma, Inc. · $14.61317 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
1 other product in the NADAC file shares the FDA nonproprietary name naloxegol oxalate with MOVANTIK 25 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| MOVANTIK 12.5 MG TABLET | $14.59872 per EA filed | $13.50292 per EA filed |
| MOVANTIK 25 MG TABLET this page | $14.61317 per EA filed | $13.50292 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 2 NDCs’ NADAC prices is $14.61317 per EA filed.
Of the 30 other products in FDA’s Opioid Antagonist class priced per EA, 14 have a higher middle NADAC price and 16 a lower one. The one in the middle is ZUBSOLV 5.7-1.4 MG TABLET SL, at $10.54312 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $405.09 for 30 tablets, at an average of $13.50292 per EA in 2024 (2024-01-01 to 2024-12-31) for “Movantik” and “Naloxegol Oxalate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 336,315 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for MOVANTIK 25 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Movantik / Naloxegol Oxalate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
Related pages
Its pharmacologic class
Related in the same class
- BUPRENORPHINE-NALOXONE 12-3 MG SL FILM
- NALOXONE 0.4 MG/ML VIAL
- NALTREXONE 50 MG TABLET
- SUBOXONE 12 MG-3 MG SL FILM
- LYBALVI 10-10 MG TABLET